Findings

What do systematic reviews say?

8 questions · 9 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 7 · 77.8%Moderate 2 · 22.2%High 0 · 0%

FIBRINOGEN: Prophylactic trials: intervention vs inactive control

Arterial thrombotic events ‐ up to 30 days post‐operatively · the prevention and treatment of bleeding in patients without haemophilia

FIBRINOGEN: Prophylactic trials: intervention showed no clear difference in arterial thrombotic events Up to 30 days post‐operatively compared with inactive control (low certainty).

2 findings from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
RR 0.33 [0.01, 8.02]
1 study · 116 participants
Low
Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 122 participants
Low

FIBRINOGEN: Prophylactic trials: intervention vs inactive control

Venous thrombotic events Up to 4 days post‐operatively · the prevention and treatment of bleeding in patients without haemophilia

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 80 participants
Moderate

FIBRINOGEN: Prophylactic trials: intervention vs haemostatically active control

Arterial thromboembolic events at 1 to 2 years · the prevention and treatment of bleeding in patients without haemophilia

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low

FIBRINOGEN: Prophylactic trials: intervention vs haemostatically active control

Arterial thromboembolic events ‐ Duration of hospital stay (whole population) · the prevention and treatment of bleeding in patients without haemophilia

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low

FIBRINOGEN: Prophylactic trials: intervention vs haemostatically active control

Venous thromboembolic events · the prevention and treatment of bleeding in patients without haemophilia

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low

FIBRINOGEN: Prophylactic trials: intervention vs haemostatically active control

Venous thromboembolic events Duration of hospital stay (whole population) · the prevention and treatment of bleeding in patients without haemophilia

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low

FIBRINOGEN: Prophylactic trials: intervention vs inactive control

Venous thromboembolic events Up to 30 days post‐operatively · the prevention and treatment of bleeding in patients without haemophilia

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 122 participants
Low

FIBRINOGEN: Prophylactic trials: intervention vs inactive control

Arterial thrombotic events Up to 4 days post‐operatively · the prevention and treatment of bleeding in patients without haemophilia

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 80 participants
Moderate